P240022/S005: Evolysse Smooth; Evolysse Form
FDA’s recorded scope: a semi-automated finger grip assembly process
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Symatese. 3 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 3, 2025 to Feb 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LMH appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P240022, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: Zi Les Troques, Chaponost, 69630. Recorded on P240022/S005, decision dated Feb 27, 2026.
FDA’s recorded scope: a semi-automated finger grip assembly process
FDA’s recorded scope: Approval for a design change to the syringe plunger rod for the Evolysse injectable hyaluronic acid gels approved under P240022
FDA’s recorded scope: Approval for changes to the Informed Consent Form used in the Post-Approval Study.
FDA’s recorded scope: approval of the protocol for the post-approval study (PAS).
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Evolysse Smooth; Evolysse FormP240022/S005 | Symatese | PMA supplement | Feb 27, 2026 | FDA |
Evolysse Injectable Hyaluronic AcidP240022/S004 | Symatese | PMA supplement | Dec 19, 2025 | FDA |
Evolysse FORMP240022/S003 | Symatese | PMA supplement | Dec 18, 2025 | FDA |
EVOLYSSE FORM and EVOLYSSE SMOOTHP240022/S001 | Symatese | PMA supplement | Sep 3, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.